Skip to content
Skip to content

Ginkgo vs Myo-Inositol for blood sugar: which has better evidence?

Myo-Inositol has the stronger evidence for blood sugar (Ginkgo Grade C vs Myo-Inositol Grade B). For blood sugar, Myo-Inositol has the stronger evidence grade.

Reviewed by Substrate editorial, Independent research collective ·

Platform evidence comparison

These existing platform assessments are separate from the source-reported findings below. They do not represent a direct trial comparing these treatments.

GinkgoMyo-Inositol
Gradegrade Cgrade B
Certaintylowmoderate
EffectMeta-analysis: Ginkgo biloba extract significantly reduced fasting blood glucose and improved insulin resistance (HOMA-IR) versus control, plus reduced BMI and waist circumference, but did NOT significantly change HbA1c or fasting insulin levels — a partial biomarker signal, not comprehensive glycemic control.improves insulin sensitivity and ovulatory function in PCOS in multiple RCTs
Studied dosevaries across trials2–4 g/day myo-inositol
Populationadults with metabolic risk factorswomen with PCOS / insulin resistance
Safety2 modeled interaction(s)0 modeled interaction(s)
Grade
C
what does the grade mean?
Certainty
low
what does certainty mean?

Grade C / low: hints of benefit in small trials; a well-run RCT could easily push this to B or to null.

Direct comparison evidence

There are no direct RCTs in our corpus comparing Ginkgo and Myo-Inositol head-to-head for blood sugar. What we present above is an indirect comparison: each side's own trials, contrasted. This is standard practice for supplement comparisons — dose, population, and outcome-instrument differences between the two evidence bases add uncertainty on top of each side's own grade.

Can you take both?

No modeled interaction between Ginkgo and Myo-Inositol in our corpus. Absence of a recorded interaction is not proof of additive benefit — combined-effect trials are usually absent for supplement pairs, so treat "stack" claims skeptically.

Decision guidance

sources: PMID:42157337 · PMID:38163998

Grade history

No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.

Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.

Frequently asked

Which has stronger evidence: Ginkgo or Myo-Inositol for blood sugar?

Ginkgo carries Grade C at low certainty; Myo-Inositol carries Grade B at moderate. The stronger evidence points to Myo-Inositol, subject to the caveat that direct head-to-head trials are usually absent for supplement pairings.

Can I take Ginkgo and Myo-Inositol together?

No modeled interaction between Ginkgo and Myo-Inositol; combining is not documented to be problematic, but combined-effect trials are also absent, so treat additive benefit claims skeptically.

Have Ginkgo and Myo-Inositol been compared head-to-head?

Direct RCTs comparing the two for blood sugar are uncommon. This page contrasts each side's own trial evidence — that is an indirect comparison, which introduces confounds from population and dose differences. See the direct-comparison block above.

What decides between Ginkgo and Myo-Inositol for me?

Read the decision guidance below — the split usually comes down to population fit, interaction risk with your other medications, and how much certainty you want behind the recommendation.

Related

Cite this page

Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.

Plain-text citation
Substrate. Ginkgo vs Myo-Inositol for blood sugar. https://evidencebased.info/compare/ginkgo-vs-inositol-for-blood-sugar. Updated 2026-07-14.
BibTeX
@misc{substrate_nositolforbloodsugar,
  author = {Substrate editorial},
  title  = {Ginkgo vs Myo-Inositol for blood sugar},
  year   = {2026},
  url    = {https://evidencebased.info/compare/ginkgo-vs-inositol-for-blood-sugar},
  note   = {evidencebased.info}
}